Novel RAAG10 cell surface target and a family of antibodies recognizing that target

Details for Australian Patent Application No. 2003243749 (hide)

Owner Raven Biotechnologies, Inc.

Inventors Pan, Zhuangyu; Mather, Jennie P.; Roberts, Penelope E.; Li, Rong-Hao

Agent FB Rice

Pub. Number AU-B-2003243749

PCT Number PCT/US03/19819

PCT Pub. Number WO2004/001381

Priority 60/390,203 19.06.02 US

Filing date 19 June 2003

Wipo publication date 6 January 2004

Acceptance publication date 11 March 2010

International Classifications

G01N 33/531 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Production of immunochemical test materials

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/02 (2006.01) Mutation or genetic engineering - Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 60/390,203 19.06.02 US

4 March 2004 Application Open to Public Inspection

  Published as AU-B-2003243749

11 March 2010 Application Accepted

  Published as AU-B-2003243749

8 July 2010 Standard Patent Sealed

16 December 2010 Alteration of Name

  The name of the patentee has been altered to MacroGenics West, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003243750-RAPIDLY DISSOLVING MICROPERFORATOR FOR DRUG DELIVERY AND OTHER APPLICATIONS

2003243748-ANIMAL MODELS OF PROSTATE CANCER AND METHODS FOR THEIR USE